Published in Transplant Proc on February 22, 2010
Polyfunctional T-Cell Signatures to Predict Protection from Cytomegalovirus after Lung Transplantation. Am J Respir Crit Care Med (2016) 1.41
Cytomegalovirus-induced immunopathology and its clinical consequences. Herpesviridae (2011) 1.19
Surveillance of γδ T Cells Predicts Cytomegalovirus Infection Resolution in Kidney Transplants. J Am Soc Nephrol (2015) 0.76
Immunological Prediction of Cytomegalovirus (CMV) Replication Risk in Solid Organ Transplantation Recipients: Approaches for Regulating the Targeted Anti-CMV Prevention Strategies. Infect Chemother (2017) 0.75
Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis (1996) 2.12
Prenatal indicators of congenital cytomegalovirus infection. J Pediatr (2000) 2.12
Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting. J Med Virol (1985) 2.09
Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria. Am J Transplant (2008) 2.06
Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control. On behalf of the Italian Study Group. Chest (2000) 2.04
Identification and procaryotic expression of the gene coding for the highly immunogenic 28-kilodalton structural phosphoprotein (pp28) of human cytomegalovirus. J Virol (1988) 2.00
The risk of adenomatous polyps in asymptomatic first-degree relatives of persons with colon cancer. Gastroenterology (1995) 1.88
Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg (2001) 1.66
Human cytomegalovirus structural proteins. J Gen Virol (1994) 1.63
Avidity of immunoglobulin G directed against human cytomegalovirus during primary and secondary infections in immunocompetent and immunocompromised subjects. Clin Diagn Lab Immunol (1997) 1.61
West Nile virus in Europe: emergence, epidemiology, diagnosis, treatment, and prevention. Clin Microbiol Infect (2013) 1.58
An appraisal of percutaneous treatment of liver metastases. Liver Transpl Surg (1998) 1.54
Liver/kidney microsomal antibody type 1 targets CYP2D6 on hepatocyte plasma membrane. Gut (2000) 1.53
Usutu virus infection in a patient who underwent orthotropic liver transplantation, Italy, August-September 2009. Euro Surveill (2009) 1.48
The PLAT Study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients. Atherosclerosis (1991) 1.40
Confirmation of correct central venous catheter position in the preoperative setting by echocardiographic "bubble-test". Minerva Anestesiol (2014) 1.40
The hepatic artery in liver transplantation and surgery: vascular anomalies in 701 cases. Clin Transplant (2001) 1.40
Use of porcine dermal collagen graft (Permacol) for hernia repair in contaminated fields. Hernia (2006) 1.36
Human cytomegalovirus morphogenesis: an ultrastructural study of the late cytoplasmic phases. Arch Virol (1988) 1.33
Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. Eur J Vasc Endovasc Surg (2005) 1.30
Anticytomegalovirus (anti-CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection. Clin Diagn Lab Immunol (1999) 1.29
Enzyme-linked immunoadsorbent assay for the detection of cytomegalovirus-IgM: comparison between eight commercial kits, immunofluorescence, and immunoblotting. J Clin Lab Anal (1992) 1.29
Liver transplantation with cavoportal hemitransposition in the presence of diffuse portal vein thrombosis. Transplantation (1998) 1.28
Analysis of intracellular and intraviral localization of the human cytomegalovirus UL53 protein. J Gen Virol (2002) 1.27
Liver transplantation for recurrent hepatocellular carcinoma on cirrhosis after liver resection: University of Bologna experience. Am J Transplant (2008) 1.27
Identification and preliminary use of recombinant lambda gt11 fusion proteins in human cytomegalovirus diagnosis. J Gen Virol (1989) 1.26
Modulation of RANTES production by human cytomegalovirus infection of fibroblasts. J Virol (1997) 1.25
Large-scale screening of human sera with cytomegalovirus recombinant antigens. J Clin Microbiol (1990) 1.25
Human cytomegalovirus glycoprotein N (gpUL73-gN) genomic variants: identification of a novel subgroup, geographical distribution and evidence of positive selective pressure. J Gen Virol (2003) 1.24
Human cytomegalovirus carries serine/threonine protein phosphatases PP1 and a host-cell derived PP2A. J Virol (1996) 1.22
Antibody response to recombinant lambda gt11 fusion proteins in cytomegalovirus infection. J Clin Microbiol (1989) 1.20
Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation. Am J Transplant (2010) 1.19
Human cytomegalovirus late-phase maturation is blocked by stably expressed UL32 antisense mRNA in astrocytoma cells. J Gen Virol (1997) 1.19
Harm and benefits of primary liver resection and salvage transplantation for hepatocellular carcinoma. Am J Transplant (2010) 1.18
Can the dropout risk of candidates with hepatocellular carcinoma predict survival after liver transplantation? Am J Transplant (2011) 1.18
Evaluation of the Abbott AxSYM cytomegalovirus (CMV) immunoglobulin M (IgM) assay in conjunction with other CMV IgM tests and a CMV IgG avidity assay. Clin Diagn Lab Immunol (2001) 1.18
Early and five-year amputation and survival rate of diabetic patients with critical limb ischemia: data of a cohort study of 564 patients. Eur J Vasc Endovasc Surg (2006) 1.16
Cytomegalovirus-mediated induction of antisense mRNA expression to UL44 inhibits virus replication in an astrocytoma cell line: identification of an essential gene. J Virol (1995) 1.15
Rapid increase of carbapenemase-producing Klebsiella pneumoniae strains in a large Italian hospital: surveillance period 1 March - 30 September 2010. Euro Surveill (2011) 1.14
Expression and characterization of a novel structural protein of human cytomegalovirus, pUL25. J Virol (1999) 1.14
Early enhanced glucose uptake in human cytomegalovirus-infected cells. J Gen Virol (1984) 1.13
Abdominal wall transplantation: surgical and immunologic aspects. Transplant Proc (2009) 1.12
Serum antibodies to individual cytomegalovirus structural polypeptides in renal transplant recipients during viral infection. Microbiol Immunol (1986) 1.12
Gastrointestinal perforations following kidney transplantation. Transplant Proc (2008) 1.12
Prenatal diagnosis of congenital cytomegalovirus infection. J Clin Microbiol (1998) 1.10
Recombinant mono- and polyantigens to detect cytomegalovirus-specific immunoglobulin M in human sera by enzyme immunoassay. J Clin Microbiol (1995) 1.10
IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients. J Med Virol (1996) 1.09
Comparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patients. Eur J Surg Oncol (2005) 1.08
A novel Western blot test containing both viral and recombinant proteins for anticytomegalovirus immunoglobulin M detection. J Clin Microbiol (1997) 1.07
Prenatal diagnosis of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol (2000) 1.07
Development of a new cytomegalovirus (CMV) immunoglobulin M (IgM) immunoblot for detection of CMV-specific IgM. J Clin Microbiol (1998) 1.07
Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors. Virology (1996) 1.06
Highly aggressive policy of hepatic resections for neuroendocrine liver metastases. Hepatogastroenterology (2000) 1.05
gpUL73 (gN) genomic variants of human cytomegalovirus isolates are clustered into four distinct genotypes. J Gen Virol (2001) 1.05
Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre. Aliment Pharmacol Ther (2003) 1.05
Human cytomegalovirus proteins. Prog Med Virol (1988) 1.02
Prokaryotic expression of a large fragment of the most antigenic cytomegalovirus DNA-binding protein (ppUL44) and its reactivity with human antibodies. J Virol Methods (1994) 1.02
Quantification of hepatitis C virus-infected peripheral blood mononuclear cells by in situ reverse transcriptase-polymerase chain reaction. Blood (1996) 1.01
The lidocaine (MEGX) test as an index of hepatic function: its clinical usefulness in liver surgery. Surgery (2000) 1.00
Humoral immune response to proteins of human cytomegalovirus latency-associated transcripts. Biol Blood Marrow Transplant (2000) 0.99
Gene expression profiling of liver metastases from colorectal cancer as potential basis for treatment choice. Br J Cancer (2008) 0.98
Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy. Clin Microbiol Infect (2011) 0.98
Cytomegalovirus replication is not a cause of instability in unstable angina. Circulation (1995) 0.98
A DNA-nicking activity associated with the nucleocapsid of human cytomegalovirus. Arch Virol (1982) 0.97
Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus. Viral Immunol (2000) 0.97
The use of social networking to explore knowledge and attitudes toward organ donation in Italy. Minerva Anestesiol (2012) 0.97
Response rate and clinical outcome of HCC after first and repeated cTACE performed "on demand". J Hepatol (2012) 0.97
Outbreak of NDM-1-producing Enterobacteriaceae in northern Italy, July to August 2011. Euro Surveill (2011) 0.96
Comparison of immunoblotting with other serological methods and virus isolation for the early detection of primary cytomegalovirus infection in allograft recipients. J Clin Microbiol (1989) 0.95
Intestinal transplantation for the treatment of desmoid tumors associated with familial adenomatous polyposis. Surgery (2001) 0.95
Human cytomegalovirus replication correlates with differentiation in a hematopoietic progenitor cell line and can be modulated by HIV-1. Arch Virol (1994) 0.95
Post-ARDS pulmonary fibrosis in patients with H1N1 pneumonia: role of follow-up CT. Radiol Med (2011) 0.95
Multivisceral transplantation for megacystis microcolon intestinal hypoperistalsis syndrome. Transplantation (1999) 0.94
Isolated resection of segment 8 for liver tumors: a new approach for anatomical segmentectomy. Arch Surg (2000) 0.94
Congenital cytomegalovirus infection: patterns of fetal brain damage. Clin Microbiol Infect (2012) 0.94
Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group. Arterioscler Thromb (1993) 0.93
Detection of serum immunoglobulin M to human cytomegalovirus by western blotting correlates better with virological data than detection by conventional enzyme immunoassay. Clin Diagn Lab Immunol (1996) 0.93
Development and clinical evaluation of a recombinant-antigen-based cytomegalovirus immunoglobulin M automated immunoassay using the Abbott AxSYM analyzer. J Clin Microbiol (2000) 0.93